{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:33:49Z","timestamp":1762223629468,"version":"build-2065373602"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001501","name":"University Grants Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["SRG\/2021\/000293"],"award-info":[{"award-number":["SRG\/2021\/000293"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.bioorg.2025.109046","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T17:18:39Z","timestamp":1758993519000},"page":"109046","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A comprehensive review of targeting sterol 14\u03b1-demethylase and sterol C-24 methyl transferase, two pivotal proteins in Leishmania, as compelling therapeutic targets"],"prefix":"10.1016","volume":"165","author":[{"given":"Diksha","family":"Kumari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somdutt","family":"Mujwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuljit","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109046_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174436","article-title":"Advancement in leishmaniasis diagnosis and therapeutics: an update","volume":"910","author":"Kumari","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0010","doi-asserted-by":"crossref","first-page":"508","DOI":"10.37349\/eds.2024.00059","article-title":"A review of leishmaniasis: current knowledge and future directions of heterocyclic molecules","volume":"2","author":"Masne","year":"2024","journal-title":"EDS"},{"year":"2022","series-title":"WHO Guideline for the Treatment of Visceral Leishmaniasis in HIV Co-Infected Patients in East Africa and South-East Asia","author":"W.H. Organization","key":"10.1016\/j.bioorg.2025.109046_bb0015"},{"key":"10.1016\/j.bioorg.2025.109046_bb0020","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1021\/acsinfecdis.4c00431","article-title":"Key facets for the elimination of vector-borne diseases filariasis, Leishmaniasis, and Malaria","volume":"11","author":"Chaturvedi","year":"2025","journal-title":"ACS infectious diseases"},{"key":"10.1016\/j.bioorg.2025.109046_bb0025","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/14787210.2024.2438627","article-title":"Anti-leishmanial therapies: overcoming current challenges with emerging therapies","volume":"23","author":"Sundar","year":"2025","journal-title":"Expert Rev. Anti-Infect. Ther."},{"key":"10.1016\/j.bioorg.2025.109046_bb0030","doi-asserted-by":"crossref","first-page":"1527946","DOI":"10.3389\/fchem.2024.1527946","article-title":"4-aminoquinoline as a privileged scaffold for the design of leishmanicidal agents: structure\u2013property relationships and key biological targets","volume":"12","author":"Romero","year":"2025","journal-title":"Front. Chem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109591","article-title":"Insights into the drug screening approaches in leishmaniasis","volume":"114","author":"Gopu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0012735","article-title":"Progress in antileishmanial drugs: mechanisms, challenges, and prospects","volume":"19","author":"Zhang","year":"2025","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2025.109046_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120829","article-title":"Virulence factors of leishmania parasite: their paramount importance in unraveling novel vaccine candidates and therapeutic targets","volume":"306","author":"Kumari","year":"2022","journal-title":"Life Sci."},{"key":"10.1016\/j.bioorg.2025.109046_bb0050","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s11274-025-04441-4","article-title":"High-throughput screening identifies novel chemical scaffolds targeting Leishmania donovani parasites","volume":"41","author":"Kumari","year":"2025","journal-title":"World J. Microbiol. Biotechnol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0055","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.pt.2023.01.010","article-title":"Drug discovery for parasitic diseases: powered by technology, enabled by pharmacology, informed by clinical science","volume":"39","author":"Rao","year":"2023","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108400","article-title":"Exploring the paradox of defense between host and Leishmania parasite","volume":"102","author":"Kumari","year":"2022","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0065","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s00436-020-06736-x","article-title":"An overview of biochemically characterized drug targets in metabolic pathways of Leishmania parasite","volume":"119","author":"Raj","year":"2020","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.bioorg.2025.109046_bb0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.drudis.2017.09.006","article-title":"Molecular targets and pathways for the treatment of visceral leishmaniasis","volume":"23","author":"Jain","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2025.109046_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108804","article-title":"Novel pyrazole derivatives as inhibitors of Leishmania donovani: an integrated approach combining in vitro analysis and mechanistic insights","volume":"164","author":"Kumari","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0080","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ejmech.2018.08.012","article-title":"An update on small molecule strategies targeting leishmaniasis","volume":"157","author":"Kapil","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0085","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.freeradbiomed.2024.01.039","article-title":"Unveiling the role of serine o-acetyltransferase in drug resistance and oxidative stress tolerance in Leishmania donovani through the regulation of thiol-based redox metabolism","volume":"213","author":"Nawaz","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bioorg.2025.109046_bb0090","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1039\/D3MD00214D","article-title":"Design, synthesis, and biological evaluation of 3,3\u2032-diindolylmethane N-linked glycoconjugate as a leishmanial topoisomerase IB inhibitor with reduced cytotoxicity","volume":"14","author":"Kour","year":"2023","journal-title":"RSC medicinal chemistry"},{"key":"10.1016\/j.bioorg.2025.109046_bb0095","doi-asserted-by":"crossref","first-page":"897","DOI":"10.2174\/1389200217666160819161444","article-title":"Current therapeutics, their problems and thiol metabolism as potential drug targets in leishmaniasis","volume":"17","author":"Singh","year":"2016","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.bioorg.2025.109046_bb0100","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.3390\/pharmaceutics14081590","article-title":"Metabolic pathways of Leishmania parasite: source of pertinent drug targets and potent drug candidates","volume":"14","author":"Jain","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2025.109046_bb0105","doi-asserted-by":"crossref","first-page":"249","DOI":"10.3390\/biom14030249","article-title":"Druggable sterol metabolizing enzymes in infectious diseases: cell targets to therapeutic leads","volume":"14","author":"Nes","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.bioorg.2025.109046_bb0110","doi-asserted-by":"crossref","first-page":"9409","DOI":"10.1038\/s41467-024-53790-5","article-title":"CYP5122A1 encodes an essential sterol C4-methyl oxidase in Leishmania donovani and determines the antileishmanial activity of antifungal azoles","volume":"15","author":"Jin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.109046_bb0115","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2174\/1389450121666200422083735","article-title":"An insight into the current perspective and potential drug targets for visceral leishmaniasis (VL)","volume":"21","author":"Mansuri","year":"2020","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.bioorg.2025.109046_bb0120","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11745-006-3017-1","article-title":"Sterol biosynthesis inhibitors: potential for transition state analogs and mechanism-based inactivators targeted at sterol methyltransferase","volume":"42","author":"Song","year":"2007","journal-title":"Lipids"},{"key":"10.1016\/j.bioorg.2025.109046_bb0125","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejmech.2017.04.044","article-title":"An overview of azoles targeting sterol 14\u03b1-demethylase for antileishmanial therapy","volume":"135","author":"Emami","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003588","article-title":"Targeting ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14alpha-demethylase","volume":"9","author":"McCall","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2025.109046_bb0135","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/mmi.14139","article-title":"Sterol methyltransferase is required for optimal mitochondrial function and virulence in Leishmania major","volume":"111","author":"Mukherjee","year":"2019","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008810","article-title":"Sterol 14-\u03b1-demethylase is vital for mitochondrial functions and stress tolerance in Leishmania major","volume":"16","author":"Mukherjee","year":"2020","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bioorg.2025.109046_bb0145","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.3390\/molecules23071753","article-title":"Synthesis and biological activity of sterol 14\u03b1-demethylase and sterol C24-methyltransferase inhibitors","volume":"23","author":"Leaver","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109046_bb0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.132034","article-title":"Anhydroparthenin as a dual-target inhibitor against sterol C-24 methyltransferase and sterol 14-\u03b1 demethylase of Leishmania donovani: a comprehensive in vitro and in silico study","volume":"269","author":"Kumari","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.138105","article-title":"Design, synthesis, and biological evaluation of eugenol-isoxazoline hybrid derivatives as potential anti-leishmanial agents","volume":"1308","author":"Rani","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2025.109046_bb0160","first-page":"1117","article-title":"In silico approaches supporting drug repurposing for leishmaniasis: a scoping review","volume":"23","author":"Scheiffer","year":"2024","journal-title":"EXCLI J."},{"key":"10.1016\/j.bioorg.2025.109046_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.128401","article-title":"DNA topoisomerases as a drug target in leishmaniasis: structural and mechanistic insights","volume":"256","author":"Kour","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2025.109753","article-title":"Computational approaches and experimental investigation for identification of potential inhibitors targeting cysteine synthase in Leishmania donovani","volume":"188","author":"Nawaz","year":"2025","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.bioorg.2025.109046_bb0175","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbrc.2007.09.093","article-title":"Sterol biosynthesis and prokaryotes-to-eukaryotes evolution","volume":"363","author":"Chen","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2025.109046_bb0180","series-title":"Developmental Biology in Prokaryotes and Lower Eukaryotes","first-page":"215","article-title":"Sterol biosynthetic pathways and their function in Bacteria","author":"Franke","year":"2021"},{"key":"10.1016\/j.bioorg.2025.109046_bb0185","doi-asserted-by":"crossref","first-page":"13478","DOI":"10.1073\/pnas.1511482112","article-title":"A distinct pathway for tetrahymanol synthesis in bacteria","volume":"112","author":"Banta","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.109046_bb0190","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1134\/S0006297916080046","article-title":"Plant sterols: diversity, biosynthesis, and physiological functions","volume":"81","author":"Valitova","year":"2016","journal-title":"Biochemistry (Mosc)"},{"key":"10.1016\/j.bioorg.2025.109046_bb0195","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1007\/s11101-020-09708-2","article-title":"The role of sterols in plant response to abiotic stress","volume":"19","author":"Rogowska","year":"2020","journal-title":"Phytochem. Rev."},{"key":"10.1016\/j.bioorg.2025.109046_bb0200","first-page":"939","article-title":"Plant sterols: biosynthesis, biological function and their importance to human nutrition","volume":"80","author":"Piironen","year":"2000"},{"key":"10.1016\/j.bioorg.2025.109046_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042332","article-title":"Biosynthesis and the roles of plant sterols in development and stress responses","volume":"23","author":"Du","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109046_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1574-6968.2010.02007.x","article-title":"Sterol biosynthesis and sterol uptake in the fungal pathogen pneumocystis carinii","volume":"311","author":"Joffrion","year":"2010","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.bioorg.2025.109046_bb0215","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1111\/j.1558-5646.2012.01667.x","article-title":"Ergosterol biosynthesis: a fungal pathway for life on land?","volume":"66","author":"Dupont","year":"2012","journal-title":"Evolution"},{"key":"10.1016\/j.bioorg.2025.109046_bb0220","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1080\/21505594.2016.1188236","article-title":"The synthesis, regulation, and functions of sterols in Candida albicans: well-known but still lots to learn","volume":"7","author":"Lv","year":"2016","journal-title":"Virulence"},{"key":"10.1016\/j.bioorg.2025.109046_bb0225","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jsbmb.2011.08.012","article-title":"Steroid-transforming enzymes in fungi","volume":"129","author":"Kristan","year":"2012","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0230","doi-asserted-by":"crossref","first-page":"1409085","DOI":"10.3389\/fmicb.2024.1409085","article-title":"Insights into the role of sterol metabolism in antifungal drug resistance: a mini-review","volume":"15","author":"Tanwar","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0235","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1080\/14728222.2018.1472241","article-title":"Emerging therapeutic targets for treatment of leishmaniasis","volume":"22","author":"Sundar","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.bioorg.2025.109046_bb0240","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.actatropica.2018.02.010","article-title":"Recent progress in drug targets and inhibitors towards combating leishmaniasis","volume":"181","author":"Vijayakumar","year":"2018","journal-title":"Acta Trop."},{"key":"10.1016\/j.bioorg.2025.109046_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0007260","article-title":"A plant like cytochrome P450 subfamily CYP710C1 gene in Leishmania donovani encodes sterol C-22 desaturase and its over-expression leads to resistance to amphotericin B","volume":"13","author":"Bansal","year":"2019","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2025.109046_bb0250","doi-asserted-by":"crossref","first-page":"262","DOI":"10.15698\/mic2021.11.764","article-title":"Lipid and Fatty Acid Metabolism in Trypanosomatids","volume":"vol. 8","author":"Parreira de Aquino","year":"2021","journal-title":"Microbial Cell (Graz, Austria)"},{"key":"10.1016\/j.bioorg.2025.109046_bb0255","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s11745-008-3225-y","article-title":"CYP51: a major drug target in the cytochrome P450 superfamily","volume":"43","author":"Lepesheva","year":"2008","journal-title":"Lipids"},{"key":"10.1016\/j.bioorg.2025.109046_bb0260","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bbagen.2006.07.018","article-title":"Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms","volume":"1770","author":"Lepesheva","year":"2007","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2025.109046_bb0265","doi-asserted-by":"crossref","first-page":"26838","DOI":"10.1074\/jbc.M111.237099","article-title":"Substrate preferences and catalytic parameters determined by structural characteristics of sterol 14alpha-demethylase (CYP51) from Leishmania infantum","volume":"286","author":"Hargrove","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0270","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/B978-0-12-385863-4.00004-6","article-title":"Targeting Trypanosoma cruzi sterol 14\u03b1-demethylase (CYP51)","volume":"75","author":"Lepesheva","year":"2011","journal-title":"Adv. Parasitol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0275","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9060696","article-title":"Unexpected role of sterol synthesis in RNA stability and translation in Leishmania","volume":"9","author":"Karamysheva","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioorg.2025.109046_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003588","article-title":"Targeting ergosterol biosynthesis in Leishmania donovani: essentiality of sterol 14 alpha-demethylase","volume":"9","author":"McCall","year":"2015","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2025.109046_bb0285","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004427","article-title":"Sterol biosynthesis is required for heat resistance but not extracellular survival in Leishmania","volume":"10","author":"Xu","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bioorg.2025.109046_bb0290","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005649","article-title":"Sterol 14\u03b1-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana","volume":"11","author":"Mwenechanya","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2025.109046_bb0295","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/642502","article-title":"Sterol biosynthesis pathway as target for anti-trypanosomatid drugs","volume":"2009","author":"de Souza","year":"2009","journal-title":"Interdisciplinary perspectives on infectious diseases"},{"key":"10.1016\/j.bioorg.2025.109046_bb0300","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010094","article-title":"Indene-derived hydrazides targeting acetylcholinesterase enzyme in Alzheimer's: design, synthesis, and biological evaluation","volume":"15","author":"Gupta","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2025.109046_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012382","article-title":"Sterol 14-alpha demethylase (CYP51) activity in Leishmania donovani is likely dependent upon cytochrome P450 reductase 1","volume":"20","author":"Tulloch","year":"2024","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.bioorg.2025.109046_bb0310","doi-asserted-by":"crossref","first-page":"42549","DOI":"10.1074\/jbc.M204223200","article-title":"Active site mapping and substrate channeling in the sterol methyltransferase pathway","volume":"277","author":"Nes","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0315","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.abb.2008.11.003","article-title":"Sterol 24-C-methyltransferase: an enzymatic target for the disruption of ergosterol biosynthesis and homeostasis in Cryptococcus neoformans","volume":"481","author":"Nes","year":"2009","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2025.109046_bb0320","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.molbiopara.2008.03.010","article-title":"Delta24(25)-sterol methenyltransferase: intracellular localization and azasterol sensitivity in Leishmania major promastigotes overexpressing the enzyme","volume":"160","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2008","journal-title":"Mol. Biochem. Parasitol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0325","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.abb.2010.10.008","article-title":"Purification, characterization and inhibition of sterol C24-methyltransferase from Candida albicans","volume":"505","author":"Ganapathy","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2025.109046_bb0330","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s12033-018-0069-4","article-title":"Combined strategies to improve the expression of recombinant sterol C24-methyltransferase from Leishmania braziliensis in E. Coli","volume":"60","author":"Freitas","year":"2018","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0335","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.bbalip.2010.06.007","article-title":"Cloning, mechanistic and functional analysis of a fungal sterol C24-methyltransferase implicated in brassicasterol biosynthesis","volume":"1801","author":"Pereira","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bioorg.2025.109046_bb0340","doi-asserted-by":"crossref","first-page":"4279","DOI":"10.1007\/s11033-014-3299-y","article-title":"Structure and dynamics studies of sterol 24-C-methyltransferase with mechanism based inactivators for the disruption of ergosterol biosynthesis","volume":"41","author":"Azam","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.bioorg.2025.109046_bb0345","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1080\/07391102.2014.1002423","article-title":"Binding pattern analysis and structural insight into the inhibition mechanism of sterol 24-C methyltransferase by docking and molecular dynamics approach","volume":"33","author":"Azam","year":"2015","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.109046_bb0350","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1016\/j.vaccine.2007.08.001","article-title":"Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant","volume":"25","author":"Goto","year":"2007","journal-title":"J Vaccine"},{"key":"10.1016\/j.bioorg.2025.109046_bb0355","doi-asserted-by":"crossref","first-page":"9670","DOI":"10.1021\/bi00030a003","article-title":"Substrate-based inhibitors of lanosterol 14 alpha-methyl demethylase: I. Assessment of inhibitor structure-activity relationship and cholesterol biosynthesis inhibition properties","volume":"34","author":"Trzaskos","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2025.109046_bb0360","doi-asserted-by":"crossref","first-page":"15149","DOI":"10.1073\/pnas.2535442100","article-title":"A class of sterol 14-demethylase inhibitors as anti-Trypanosoma cruzi agents","volume":"100","author":"Buckner","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.109046_bb0365","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1645\/GE-1259.1","article-title":"Mode of action of fenarimol against Leishmania spp","volume":"94","author":"Zeiman","year":"2008","journal-title":"J. Parasitol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0370","doi-asserted-by":"crossref","first-page":"25582","DOI":"10.1074\/jbc.M110.133215","article-title":"Structural insights into inhibition of sterol 14alpha-demethylase in the human pathogen Trypanosoma cruzi","volume":"285","author":"Lepesheva","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0375","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1194\/jlr.M021865","article-title":"Structural complex of sterol 14\u03b1-demethylase (CYP51) with 14\u03b1-methylenecyclopropyl-\u03947-24, 25-dihydrolanosterol","volume":"53","author":"Hargrove","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bioorg.2025.109046_bb0380","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ijpddr.2012.06.001","article-title":"CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds","volume":"2","author":"Hargrove","year":"2012","journal-title":"Int. J. Parasitol. Drugs Drug Resist."},{"key":"10.1016\/j.bioorg.2025.109046_bb0385","doi-asserted-by":"crossref","first-page":"7651","DOI":"10.1021\/jm401067s","article-title":"Rational development of 4-aminopyridyl-based inhibitors targeting Trypanosoma cruzi CYP51 as anti-chagas agents","volume":"56","author":"Choi","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0390","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1002\/cbic.201402027","article-title":"Expanding the binding envelope of CYP51 inhibitors targeting Trypanosoma cruzi with 4-Aminopyridyl-based sulfonamide derivatives","volume":"15","author":"Vieira","year":"2014","journal-title":"Chembiochem"},{"key":"10.1016\/j.bioorg.2025.109046_bb0395","doi-asserted-by":"crossref","first-page":"10162","DOI":"10.1021\/jm501568b","article-title":"Binding mode and potency of N-indolyloxopyridinyl-4-aminopropanyl-based inhibitors targeting Trypanosoma cruzi CYP51","volume":"57","author":"Vieira","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0400","doi-asserted-by":"crossref","first-page":"6989","DOI":"10.1021\/jm500448u","article-title":"4-Aminopyridyl-based CYP51 inhibitors as anti-Trypanosoma cruzi drug leads with improved pharmacokinetic profile and in vivo potency","volume":"57","author":"Calvet","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0405","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006132","article-title":"4-aminopyridyl-based lead compounds targeting CYP51 prevent spontaneous parasite relapse in a chronic model and improve cardiac pathology in an acute model of Trypanosoma cruzi infection","volume":"11","author":"Calvet","year":"2017","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2025.109046_bb0410","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jgar.2018.05.007","article-title":"Promising antileishmanial activity of novel imidazole antifungal drug luliconazole against Leishmania major: in vitro and in silico studies","volume":"14","author":"Shokri","year":"2018","journal-title":"J Glob Antimicrob Resist"},{"key":"10.1016\/j.bioorg.2025.109046_bb0415","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s00436-019-06206-z","article-title":"In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14\u03b1-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei","volume":"118","author":"Rojas Vargas","year":"2019","journal-title":"Parasitol. Res."},{"key":"10.1016\/j.bioorg.2025.109046_bb0420","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1002\/cmdc.202000250","article-title":"Claire small-molecule inhibitors targeting sterol 14\u03b1-demethylase (CYP51): synthesis, molecular modelling and evaluation against Candida albicans","volume":"15","author":"Binjubair","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2025.109046_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.carres.2020.108130","article-title":"Novel mannopyranoside esters as sterol 14\u03b1-demethylase inhibitors: synthesis, PASS predication, molecular docking, and pharmacokinetic studies","volume":"496","author":"Matin","year":"2020","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.bioorg.2025.109046_bb0430","doi-asserted-by":"crossref","first-page":"7762","DOI":"10.1080\/07391102.2021.1902396","article-title":"Antifungal activity of amino-alcohols based cationic surfactants and in silico, homology modeling, docking and molecular dynamics studies against lanosterol 14-\u03b1-demethylase enzyme","volume":"40","author":"Hafidi","year":"2022","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.109046_bb0435","first-page":"648","article-title":"In vitro and in silico evaluations of the antileishmanial activities of new benzimidazole-triazole derivatives","volume":"10","author":"Eser","year":"2023","journal-title":"Vet. Sci."},{"key":"10.1016\/j.bioorg.2025.109046_bb0440","doi-asserted-by":"crossref","first-page":"37781","DOI":"10.1021\/acsomega.3c01722","article-title":"Synthesis, Antifungal Ergosterol Inhibition, Antibiofilm Activities, and Molecular Docking on \u03b2-Tubulin and Sterol 14-Alpha Demethylase along with DFT-Based Quantum Mechanical Calculation of Pyrazole Containing Fused Pyridine\u2013Pyrimidine Derivatives","volume":"8","author":"Desai","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2025.109046_bb0445","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1021\/jm021114j","article-title":"Ruiz-Perez, Azasterols as inhibitors of sterol 24-methyltransferase in Leishmania species and Trypanosoma cruzi","volume":"46","author":"Magaraci","year":"2003","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0450","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1128\/AAC.48.8.2937-2950.2004","article-title":"Novel azasterols as potential agents for treatment of leishmaniasis and trypanosomiasis","volume":"48","author":"Orenes Lorente","year":"2004","journal-title":"J. Antimicrob. Agents"},{"key":"10.1016\/j.bioorg.2025.109046_bb0455","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s11745-004-1290-7","article-title":"Disruption of ergosterol biosynthesis, growth, and the morphological transition in Candida albicans by sterol methyltransferase inhibitors containing sulfur at C-25 in the sterol side chain","volume":"39","author":"Kanagasabai","year":"2004","journal-title":"Lipids"},{"key":"10.1016\/j.bioorg.2025.109046_bb0460","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1128\/AAC.01508-05","article-title":"New azasterols against Trypanosoma brucei: role of 24-sterol methyltransferase in inhibitor action","volume":"50","author":"Gros","year":"2006","journal-title":"J. Antimicrob. Agents"},{"key":"10.1016\/j.bioorg.2025.109046_bb0465","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.abb.2010.10.008","article-title":"Purification, characterization and inhibition of sterol C24-methyltransferase from Candida albicans","volume":"505","author":"Ganapathy","year":"2011","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.bioorg.2025.109046_bb0470","doi-asserted-by":"crossref","first-page":"6290","DOI":"10.1074\/jbc.M511749200","article-title":"Mechanistic analysis of a multiple product sterol methyltransferase implicated in ergosterol biosynthesis in Trypanosoma brucei","volume":"281","author":"Zhou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0475","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1194\/jlr.M600404-JLR200","article-title":"Cholesterol import fails to prevent catalyst-based inhibition of ergosterol synthesis and cell proliferation of Trypanosoma brucei","volume":"48","author":"Zhou","year":"2007","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.bioorg.2025.109046_bb0480","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.chembiol.2015.08.017","article-title":"Fluorinated sterols are suicide inhibitors of ergosterol biosynthesis and growth in Trypanosoma brucei","volume":"22","author":"Leaver","year":"2015","journal-title":"Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0485","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1016\/j.bmc.2013.04.063","article-title":"Anti-leishmanial evaluation of C2-aryl quinolines: mechanistic insight on bioenergetics and sterol biosynthetic pathway of Leishmania braziliensis","volume":"21","author":"Bompart","year":"2013","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0490","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/jcb.29944","article-title":"Virtual screening of natural compounds for potential inhibitors of sterol C-24 methyltransferase of Leishmania donovani to overcome leishmaniasis","volume":"122","author":"Rahman","year":"2021","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bioorg.2025.109046_bb0495","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/ddr.21820","article-title":"Repurposing of FDA-approved drugs as inhibitors of sterol C-24 methyltransferase of Leishmania donovani to fight against leishmaniasis","volume":"82","author":"Tabrez","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.bioorg.2025.109046_bb0500","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.859981","article-title":"Homology modeling, de novo design of ligands, and molecular docking identify potential inhibitors of Leishmania donovani 24-sterol methyltransferase","volume":"12","author":"Sakyi","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.bioorg.2025.109046_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.imu.2023.101162","article-title":"Targeting Leishmania donovani sterol methyltransferase for leads using pharmacophore modeling and computational molecular mechanics studies","volume":"37","author":"Sakyi","year":"2023","journal-title":"Inform. Med. Unlocked."},{"key":"10.1016\/j.bioorg.2025.109046_bb0510","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3390\/ph16030330","article-title":"Inhibiting Leishmania donovani sterol methyltransferase to identify Lead compounds using molecular modelling","volume":"16","author":"Sakyi","year":"2023","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.bioorg.2025.109046_bb0515","doi-asserted-by":"crossref","first-page":"14473","DOI":"10.1080\/07391102.2023.2193983","article-title":"Retinoic acid shows direct parasiticidal activity by targeting ergosterol pathway in Leishmania donovani: a potential therapeutic advancement","volume":"41","author":"Prakash","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.bioorg.2025.109046_bb0520","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.3390\/molecules27175727","article-title":"Virtual screening of alkaloid and terpenoid inhibitors of SMT expressed in Naegleria sp","volume":"27","author":"Abraham","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109046_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107473","article-title":"Harnessing computational and experimental approaches to identify potent hits against Leishmania donovani sterol C-24 methyltransferase from ChemBridge library","volume":"260","author":"Kumari","year":"2024","journal-title":"Acta Trop."},{"key":"10.1016\/j.bioorg.2025.109046_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2024.107338","article-title":"Repurposing FDA approved drugs against sterol C-24 methyltransferase of Leishmania donovani: a dual in silico and in vitro approach","volume":"258","author":"Kumari","year":"2024","journal-title":"Acta Trop."},{"key":"10.1016\/j.bioorg.2025.109046_bb0535","first-page":"1","article-title":"Exploring natural product library as potential target against sterol C-24 methyltransferase protein of Leishmania donovani","author":"Kumari","year":"2024","journal-title":"Nat. Prod. Res."},{"key":"10.1016\/j.bioorg.2025.109046_bb0540","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bioorg.2025.109046_bb0545","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/17460441.2021.1858793","article-title":"The latest automated docking technologies for novel drug discovery","volume":"16","author":"Caballero","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"10.1016\/j.bioorg.2025.109046_bb0550","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1073\/pnas.1324245111","article-title":"Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer","volume":"111","author":"Monk","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.bioorg.2025.109046_bb0555","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.actatropica.2009.10.023","article-title":"Specific chemotherapy of chagas disease: relevance, current limitations and new approaches","volume":"115","author":"Urbina","year":"2010","journal-title":"Acta Trop."},{"issue":"Suppl. 1","key":"10.1016\/j.bioorg.2025.109046_bb0560","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1590\/S0074-02762009000900041","article-title":"Ergosterol biosynthesis and drug development for chagas disease","volume":"104","author":"Urbina","year":"2009","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.bioorg.2025.109046_bb0565","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000651","article-title":"Structural characterization of CYP51 from Trypanosoma cruzi and Trypanosoma brucei bound to the antifungal drugs posaconazole and fluconazole","volume":"4","author":"Chen","year":"2010","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.bioorg.2025.109046_bb0570","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3390\/90400185","article-title":"Mechanism-based enzyme inactivators of phytosterol biosynthesis","volume":"9","author":"Zhou","year":"2004","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109046_bb0575","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15698\/cst2022.01.261","article-title":"Rethinking the bioavailability and cellular transport properties of S-adenosylmethionine","volume":"6","author":"Sun","year":"2022","journal-title":"Cell stress"},{"key":"10.1016\/j.bioorg.2025.109046_bb0580","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010049","article-title":"A guide to in silico drug design","volume":"15","author":"Chang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2025.109046_bb0585","article-title":"Application of fragment-based drug discovery to versatile","volume":"7","author":"Li","year":"2020","journal-title":"Targets"},{"key":"10.1016\/j.bioorg.2025.109046_bb0590","doi-asserted-by":"crossref","DOI":"10.3390\/microorganisms13040862","article-title":"Regulation of ergosterol biosynthesis in pathogenic Fungi: opportunities for therapeutic development","volume":"13","author":"Song","year":"2025","journal-title":"Microorganisms"},{"key":"10.1016\/j.bioorg.2025.109046_bb0595","first-page":"553","article-title":"Characterization of an allosteric inhibitor of fungal-specific C-24 sterol methyltransferase to treat Candida albicans infections, cell","volume":"30","author":"Jin","year":"2023","journal-title":"Chem. Biol."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009265?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825009265?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T02:32:13Z","timestamp":1762223533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825009265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":119,"alternative-id":["S0045206825009265"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109046","relation":{},"ISSN":["0045-2068"],"issn-type":[{"type":"print","value":"0045-2068"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive review of targeting sterol 14\u03b1-demethylase and sterol C-24 methyl transferase, two pivotal proteins in Leishmania, as compelling therapeutic targets","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109046"}}